GATA3 Immunohistochemical Expression in Salivary Gland Neoplasms

Head and Neck Pathology

Volumn 7, Issue 4, 2013, Pages 311-315

  Schwartz, Lauren E ^a   Begum, Shahnaz ^a   Westra, William H ^a,b   Bishop, Justin A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

GATA3; Immunohistochemistry; Mammary analogue secretory carcinoma; Salivary duct carcinoma; Salivary glands

Indexed keywords

TRANSCRIPTION FACTOR GATA 3; TUMOR MARKER;

ARTICLE; BIOSYNTHESIS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; SALIVARY GLAND; SALIVARY GLAND TUMOR; TISSUE MICROARRAY;

GATA3 TRANSCRIPTION FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; SALIVARY GLAND NEOPLASMS; SALIVARY GLANDS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84886752876     PISSN: 1936055X     EISSN: 19360568     Source Type: Journal    
DOI: 10.1007/s12105-013-0442-3     Document Type: Article

References (20)

1. Kouros-Mehr H, Slorach EM, Sternlicht MD, et al. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell. 2006;127: 1041-55.
2. Asselin-Labat ML, Sutherland KD, Barker H, et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol. 2007;9: 201-9.
3. Hendriks RW, Nawijn MC, Engel JD, et al. Expression of the transcription factor GATA-3 is required for the development of the earliest T cell progenitors and correlates with stages of cellular proliferation in the thymus. Eur J Immunol. 1999;29: 1912-8.
4. Grote D, Souabni A, Busslinger M, et al. Pax 2/8-regulated Gata 3 expression is necessary for morphogenesis and guidance of the nephric duct in the developing kidney. Development. 2006;133: 53-61.
5. Labastie MC, Catala M, Gregoire JM, et al. The GATA-3 gene is expressed during human kidney embryogenesis. Kidney Int. 1995;47: 1597-603.
6. Tsarovina K, Pattyn A, Stubbusch J, et al. Essential role of Gata transcription factors in sympathetic neuron development. Development. 2004;131: 4775-86.
7. Kaufman CK, Zhou P, Pasolli HA, et al. GATA-3: an unexpected regulator of cell lineage determination in skin. Genes Dev. 2003;17: 2108-22.
8. Liu H, Shi J, Wilkerson ML, et al. Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas. Am J Clin Pathol. 2012;138: 57-64.
9. Higgins JP, Kaygusuz G, Wang L, et al. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray. Am J Surg Pathol. 2007;31: 673-80.
10. Yang M, Nonaka D. A study of immunohistochemical differential expression in pulmonary and mammary carcinomas. Mod Pathol. 2010;23: 654-61.
11. Chang A, Amin A, Gabrielson E, et al. Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung. Am J Surg Pathol. 2012;36: 1472-6.
12. Gruver AM, Amin MB, Luthringer DJ, et al. Selective immunohistochemical markers to distinguish between metastatic high-grade urothelial carcinoma and primary poorly differentiated invasive squamous cell carcinoma of the lung. Arch Pathol Lab Med. 2012;136: 1339-46.
13. Skalova A, Vanecek T, Sima R, et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol. 2010;34: 599-608.
14. Bishop JA, et al. Cytopathologic features of mammary analogue secretory carcinoma. Cancer Cytopathol. 2012. doi: 10. 1002/cncy. 21245.
15. Bishop JA, Yonescu R, Batista D, Eisele DW, et al. Most non-parotid "acinic cell carcinomas" represent mammary analoge secretory carcinomas. Am J Surg Pathol. 2013;In Press.
16. Engelsen IB, Stefansson IM, Akslen LA, et al. GATA3 expression in estrogen receptor alpha-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival. Am J Obstet Gynecol. 2008; 199: 543 e541-547.
17. Wick MR, Ockner DM, Mills SE, et al. Homologous carcinomas of the breasts, skin, and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma. Am J Clin Pathol. 1998;109: 75-84.
18. Swanson PE, Pettinato G, Lillemoe TJ, et al. Gross cystic disease fluid protein-15 in salivary gland tumors. Arch Pathol Lab Med. 1991;115: 158-63.
19. Wick MR, Lillemoe TJ, Copland GT, Swanson PE, Manivel JC, Kiang DT. Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin. Hum Pathol. 1989;20: 281-7.
20. Ellis GL, Auclair PL. Salivary duct carcinoma. AFIP atlas of tumor pathology: tumors of the salivary glands. Washington, D. C.: ARP Press, 2008: 322-332.